On Nov. 30, 2023, API “Icodextrin” was registered on the public platform of Center for Drug Evaluation (CDE), NMPA, with ref. No. Y20230001098. Meanwhile, the dossier of API “Icodextrin” have been submitted to the authorities of Greece and Denmark, ref. No. were assigned accordingly.?
Since its establishment in 2005 and put into operation, Wuhan HUST Life Science & Technology Co., Ltd. has formed a leading enterprise in the production of polysaccharide and protein polymer API, mainly including hydroxyethyl starch, Iron Proteinsuccinylate and lcodextrin.
The company bases itself on domestic market, faces international market, we sincerely invite your cooperation!
